 |
PDBsum entry 1syi
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1syi
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Membrane protein
|
 |
|
Title:
|
 |
X-ray structure of the y702f mutant of the glur2 ligand-binding core (s1s2j) in complex with (s)-cpw399 at 2.1 a resolution.
|
|
Structure:
|
 |
Glutamate receptor 2. Chain: a, b. Fragment: glur2-flop ligand-binding core (s1s2j). Synonym: glur-2, glur-b, glur-k2, glutamate receptor ionotropic, ampa 2. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Gene: gria2, glur2. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.206
|
R-free:
|
0.254
|
|
|
Authors:
|
 |
A.Frandsen,D.S.Pickering,B.Vestergaard,C.Kasper,B.B.Nielsen, J.R.Greenwood,G.Campiani,M.Gajhede,A.Schousboe,J.S.Kastrup
|
|
Key ref:
|
 |
A.Frandsen
et al.
(2005).
Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
Mol Pharmacol,
67,
703-713.
PubMed id:
|
 |
|
Date:
|
 |
|
01-Apr-04
|
Release date:
|
22-Mar-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P19491
(GRIA2_RAT) -
Glutamate receptor 2 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
883 a.a.
259 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Mol Pharmacol
67:703-713
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
|
|
A.Frandsen,
D.S.Pickering,
B.Vestergaard,
C.Kasper,
B.B.Nielsen,
J.R.Greenwood,
G.Campiani,
C.Fattorusso,
M.Gajhede,
A.Schousboe,
J.S.Kastrup.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Ionotropic glutamate receptors mediate most rapid excitatory synaptic
transmission in the mammalian central nervous system, and their involvement in
neurological diseases has stimulated widespread interest in their structure and
function. Despite a large number of agonists developed so far, few display
selectivity among (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionic acid
(AMPA)-receptor subtypes. The present study provides X-ray structures of the
glutamate receptor 2 (GluR2)-selective partial agonist
(S)-2-amino-3-(1,3,5,6,7-pentahydro-2,4-dioxocyclopenta[e] pyrimidin-1-yl)
propanoic acid [(S)-CPW399] in complex with the ligand-binding core of GluR2
(GluR2-S1S2J) and with a (Y702F)GluR2-S1S2J mutant. In addition, the structure
of the nonselective partial agonist kainate in complex with (Y702F)GluR2-S1S2J
was determined. The results show that the selectivity of (S)-CPW399 toward
full-length GluR2 relative to GluR3 is reflected in the binding data on the two
soluble constructs, allowing the use of (Y702F)GluR2-S1S2J as a model system for
studying GluR2/GluR3 selectivity. Structural comparisons suggest that
selectivity arises from disruption of a water-mediated network between ligand
and receptor. A D1-D2 domain closure occurs upon agonist binding. (S)-CPW399 and
kainate induce greater domain closure in the Y702F mutant, indicating that these
partial agonists here act in a manner more reminiscent of full agonists. Both
kainate and (S)-CPW399 exhibited higher efficacy at (Y702F)GluR2(Q)i than at
wild-type GluR2(Q)i. Whereas an excellent correlation exists between domain
closure and efficacy of a range of agonists at full-length GluR2 determined by
electrophysiology in Xenopus laevis oocytes, a direct correlation between
agonist induced domain closure of (Y702F)GluR2-S1S2J and efficacy at the GluR3
receptor is not observed. Although it clearly controls selectivity, mutation of
this residue alone is insufficient to explain agonist-induced conformational
rearrangements occurring in this variant.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.S.Kristensen,
M.A.Jenkins,
T.G.Banke,
A.Schousboe,
Y.Makino,
R.C.Johnson,
R.Huganir,
and
S.F.Traynelis
(2011).
Mechanism of Ca(2+)/calmodulin-dependent kinase II regulation of AMPA receptor gating.
|
| |
Nat Neurosci,
14,
727-735.
|
 |
|
|
|
|
 |
J.Pøhlsgaard,
K.Frydenvang,
U.Madsen,
and
J.S.Kastrup
(2011).
Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.
|
| |
Neuropharmacology,
60,
135-150.
|
 |
|
|
|
|
 |
L.Bunch,
and
P.Krogsgaard-Larsen
(2009).
Subtype selective kainic acid receptor agonists: discovery and approaches to rational design.
|
| |
Med Res Rev,
29,
3.
|
 |
|
|
|
|
 |
A.Gill,
A.Birdsey-Benson,
B.L.Jones,
L.P.Henderson,
and
D.R.Madden
(2008).
Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists.
|
| |
Biochemistry,
47,
13831-13841.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.J.Bjerrum,
and
P.C.Biggin
(2008).
Rigid body essential X-ray crystallography: distinguishing the bend and twist of glutamate receptor ligand binding domains.
|
| |
Proteins,
72,
434-446.
|
 |
|
|
|
|
 |
M.J.Cuneo,
L.S.Beese,
and
H.W.Hellinga
(2008).
Ligand-induced conformational changes in a thermophilic ribose-binding protein.
|
| |
BMC Struct Biol,
8,
50.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.H.Kaae,
K.Harpsøe,
J.S.Kastrup,
A.C.Sanz,
D.S.Pickering,
B.Metzler,
R.P.Clausen,
M.Gajhede,
P.Sauerberg,
T.Liljefors,
and
U.Madsen
(2007).
Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites.
|
| |
Chem Biol,
14,
1294-1303.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.E.Chen,
and
D.J.Wyllie
(2006).
Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.
|
| |
Br J Pharmacol,
147,
839-853.
|
 |
|
|
|
|
 |
M.L.Mayer
(2005).
Glutamate receptor ion channels.
|
| |
Curr Opin Neurobiol,
15,
282-288.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |